Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

clinical trial

Details

Instance of: clinical trial
Start time: December 2016
End time: August 2018
Country: United States
Main subject: nivolumab
clinical trial phase: phase II clinical trial
contributor to the creative work or subject: Bristol-Myers Squibb
minimum age: 18
number of participants: 6
study type: interventional study
title: Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

Nothing in the MetaHistoryBook collection references this item yet.